Amgen (AMGN) stock forecast for 2022
The forecast has been updated: June 29, 2022 9:24
Amgen stock price online today
Analyst Target Price
250.03Dividend Date
08.06.2022Ex Dividend Date
16.05.2022Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Amgen stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Amgen stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $250.03 target price for Amgen stock stock.
Today 200 Day Moving Average is the support level (227.2 $).
50 Day Moving Average is the support level (244.41 $).
AMGN Forecast for 2022
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jul | 262.21 | 254.98 | 283.29 | 10.00 % |
Aug | 288.33 | 262.72 | 303.55 | 13.45 % |
Sep | 282.45 | 258.72 | 305.83 | 15.40 % |
Oct | 252.28 | 230.79 | 260.76 | 11.49 % |
Nov | 224.73 | 203.97 | 234.98 | 13.20 % |
Dec | 215.56 | 207.54 | 231.60 | 10.39 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Amgen stock.
Amgen overview
Amgen Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, USMarket Capitalization
130 798 871 000 $EBITDA
12 892 000 000PE Ratio
24.19PEG Ratio
1.421Dividend Per Share
7.22Dividend Yield
0.0325EPS
10.12Quarterly Earnings Growth YOY
-0.053Quarterly Revenue Growth YOY
0.057Trailing PE
24.19Forward PE
13.42EV To Revenue
5.99EV To EBITDA
14.1752 Week High
257.9752 Week Low
195.3850 Day Moving Average
244.41200 Day Moving Average
227.2Shares Outstanding
534200000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Amgen stock forecast for this year
Amgen stock forecast for Jul 2022.
Estimated Average Forecasted Amgen Price: 262.21. Positive monthly dynamics of the instrument is expected with 9.996% volatility is expected.
Pessimistic forecast: 254.98
Optimistic: 283.29
Amgen stock forecast for Aug 2022.
Estimated Average Forecasted Amgen Price: 288.33. Positive monthly dynamics of the instrument is expected with 13.450% volatility is expected.
Pessimistic forecast: 262.72
Optimistic: 303.55
Amgen stock forecast for Sep 2022.
Estimated Average Forecasted Amgen Price: 282.45. Negative monthly dynamics of the instrument is expected with 15.405% volatility is expected.
Pessimistic forecast: 258.72
Optimistic: 305.83
Amgen stock forecast for Oct 2022.
Estimated Average Forecasted Amgen Price: 252.28. Negative monthly dynamics of the instrument is expected with 11.494% volatility is expected.
Pessimistic forecast: 230.79
Optimistic: 260.76
Amgen stock forecast for Nov 2022.
Estimated Average Forecasted Amgen Price: 224.73. Negative monthly dynamics of the instrument is expected with 13.198% volatility is expected.
Pessimistic forecast: 203.97
Optimistic: 234.98
Amgen stock forecast for Dec 2022.
Estimated Average Forecasted Amgen Price: 215.56. Negative monthly dynamics of the instrument is expected with 10.387% volatility is expected.
Pessimistic forecast: 207.54
Optimistic: 231.60
Other Healthcare sector assets
Name | Symbol | Last Close Price | Change |
---|---|---|---|
Abbott Laboratories
|
ABT | 109.1 (29.06.2022) | 1.99 % |
AbbVie Inc.
|
ABBV | 154.14 (29.06.2022) | 1.08 % |
Aeterna Zentaris Inc.
|
AEZS | 0.2528 (29.06.2022) | 40.37 % |
Allakos Inc.
|
ALLK | 3.32 (29.06.2022) | 2.79 % |
Allogene Therapeutics, Inc.
|
ALLO | 11.68 (29.06.2022) | 1.74 % |
Amgen Inc.
|
AMGN | 245.43 (29.06.2022) | 0.79 % |
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
Atara Biotherapeutics, Inc.
|
ATRA | 7.58 (29.06.2022) | 15.73 % |
Aurora Cannabis Inc.
|
ACB | 1.37 (29.06.2022) | -8.05 % |
Becton Dickinson and Company
|
BDX | 249.34 (29.06.2022) | 1.97 % |
Biogen Inc.
|
BIIB | 205.23 (29.06.2022) | 1.34 % |
Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 145.65 (29.06.2022) | 0.85 % |
BioNTech SE
|
BNTX | 141.98 (29.06.2022) | 1.54 % |
bluebird bio, Inc.
|
BLUE | 4.58 (29.06.2022) | 13.37 % |
Boston Scientific Corp.
|
BSX | 37.8 (29.06.2022) | 0.80 % |
Bristol-Myers Squibb Company
|
BMY | 78.28 (29.06.2022) | -0.53 % |
Canopy Growth Corp.
|
CGC | 3.5 (29.06.2022) | -3.05 % |
Castle Biosciences, Inc.
|
CSTL | 23.01 (29.06.2022) | 0.13 % |
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
Emergent BioSolutions Inc.
|
EBS | 30.53 (29.06.2022) | -2.30 % |
Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
G1 Therapeutics, Inc.
|
GTHX | 5.09 (29.06.2022) | -1.74 % |
Gilead Sciences, Inc.
|
GILD | 62.48 (29.06.2022) | 0.43 % |
GlaxoSmithKline plc
|
GSK | 43.77 (29.06.2022) | 0.97 % |
GoodRx Holdings, Inc.
|
GDRX | 6.3 (29.06.2022) | -3.96 % |
GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
Incyte Corp.
|
INCY | 75.89 (29.06.2022) | 0.34 % |
Inovio Pharmaceuticals, Inc.
|
INO | 1.79 (29.06.2022) | -1.65 % |
Johnson & Johnson
|
JNJ | 176.99 (29.06.2022) | 0.03 % |
Medtronic plc.
|
MDT | 90.42 (29.06.2022) | 1.37 % |
Merck & Co., Inc.
|
MRK | 92.51 (29.06.2022) | 0.67 % |
Moderna, Inc.
|
MRNA | 142.81 (29.06.2022) | 0.44 % |
Novartis AG
|
NVS | 84.77 (29.06.2022) | 0.71 % |
Novavax, Inc.
|
NVAX | 51.85 (29.06.2022) | 1.55 % |
ObsEva SA
|
OBSV | 1.68 (29.06.2022) | -2.33 % |
OrganiGram Holdings Inc.
|
OGI | 0.97 (29.06.2022) | -3.96 % |
Pfizer Inc.
|
PFE | 50.94 (29.06.2022) | 0.55 % |
Regeneron Pharmaceuticals, Inc.
|
REGN | 597.62 (29.06.2022) | 0.54 % |
Sanofi
|
SNY | 52.67 (29.06.2022) | 1.02 % |
Schrodinger, Inc.
|
SDGR | 27.55 (29.06.2022) | -1.15 % |
Senseonics Holdings, Inc.
|
SENS | 1.01 (29.06.2022) | 0.00 % |
Sorrento Therapeutics, Inc.
|
SRNE | 1.99 (29.06.2022) | 1.53 % |
Stryker Corp.
|
SYK | 199.43 (29.06.2022) | 0.82 % |
Sundial Growers Inc.
|
SNDL | 0.3412 (29.06.2022) | -6.98 % |
Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 7.95 (29.06.2022) | 1.53 % |
Thermo Fisher Scientific Inc.
|
TMO | 535.92 (29.06.2022) | 0.03 % |
Tilray, Inc.
|
TLRY | 3.31 (29.06.2022) | -3.78 % |
UnitedHealth Group, Inc.
|
UNH | 515.71 (29.06.2022) | 1.43 % |
Veeva Systems Inc.
|
VEEV | 199.74 (29.06.2022) | -0.38 % |
Zomedica Corp.
|
ZOM | 0.2207 (29.06.2022) | -12.73 % |
Zynerba Pharmaceuticals, Inc.
|
ZYNE | 1.15 (29.06.2022) | -6.50 % |
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.